Rhenman & Partners Asset Management AB »

Dianthus Therapeutics shares owned by Rhenman & Partners Asset Management AB

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Rhenman & Partners Asset Management AB from 13F filings

Historical chart of Rhenman & Partners Asset Management AB investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Rhenman & Partners Asset Management AB

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.8M 174k 39.35
2025-06-30 $2.4M 127k 18.63
2025-03-31 $2.3M 127k 18.14
2024-12-31 $2.5M 114k 21.80
2024-09-30 $4.1M 150k 27.38